DiaGenic grants Pfizer non-exclusive worldwide rights to use its gene expression technology for MCI diagnostics to identify biomarkers for early stage AD

DiaGenic ASA

Norway / Medical Devices and Diagnostics

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Pfizer Inc.

U.S. / Large-Cap Biopharma (>=$50 billion)

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced